Tevogen Bio Secures $6 Million Series C Preferred Stock Investment
August 22, 2024 09:00 ET
|
Tevogen Bio Inc
WARREN, N.J., Aug. 22, 2024 (GLOBE NEWSWIRE) -- Tevogen Bio Holdings Inc. (“Tevogen” or “Tevogen Bio”) (Nasdaq: TVGN), a clinical-stage specialty immunotherapy biotech pioneer developing...
Above Food Strengthens its Pet Food Ingredient Platform with Recent Montana-Based Asset Acquisition
August 22, 2024 08:45 ET
|
Above Food
Acquisition expands Above Food's pet food business to approximately US$110M of combined company revenues on a proforma basis Strengthens customer base, further bolstering Above Food’s current...
Star Equity Holdings, Inc. Adopts Rights Agreement to Protect its Net Operating Losses
August 22, 2024 08:30 ET
|
Star Equity Holdings, Inc.
OLD GREENWICH, Conn., Aug. 22, 2024 (GLOBE NEWSWIRE) -- Star Equity Holdings, Inc. (Nasdaq: STRR; STRRP) (“Star Equity” or the “Company”), a diversified holding company, announced today that its...
Microbot Medical Signs Phase 2 Collaboration Agreement with Corewell Health to Advance Remote Telesurgery Using the LIBERTY® Endovascular Robotic System
August 22, 2024 08:30 ET
|
Microbot Medical Inc.
The agreement follows the successful completion of Phase 1 which evaluated the viability of LIBERTY as a remote telesurgery platform The objective of Phase 2 is to develop and demonstrate new...
Humic-based Biostimulants Market is Expected to Grow $1,184 million by 2027
August 22, 2024 08:30 ET
|
MarketsandMarkets Research Pvt. Ltd.
Chicago, Aug. 22, 2024 (GLOBE NEWSWIRE) -- The global humic-based biostimulants market is estimated at USD 686 million in 2022; it is projected to grow at a CAGR of 11.5% to reach USD 1,184 million...
Global Adaptive Stroller Market Size To Worth USD 1024.31 Million By 2033 | CAGR Of 7.75%
August 22, 2024 08:00 ET
|
SPHERICAL INSIGHTS LLP
New York, United States , Aug. 22, 2024 (GLOBE NEWSWIRE) -- The Global Adaptive Stroller Market Size is to Grow from USD 485.65 Million in 2023 to USD 1024.31 Million by 2033, at a Compound Annual...
Cognition Therapeutics Publishes EEG Findings from Phase 2 SEQUEL Study of CT1812 in Mild-to-Moderate Alzheimer’s Disease
August 22, 2024 07:31 ET
|
Cognition Therapeutics, Inc.
PURCHASE, N.Y., Aug. 22, 2024 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc., (the “Company” or “Cognition”) (NASDAQ: CGTX), a clinical stage company developing drugs that treat neurodegenerative...
Global Tendon Repair Market Size To Worth USD 5.11 Billion By 2033 | CAGR Of 8.40%
August 22, 2024 07:00 ET
|
SPHERICAL INSIGHTS LLP
New York, United States, Aug. 22, 2024 (GLOBE NEWSWIRE) -- The Global Tendon Repair Market Size is to grow from USD 2.28 Billion in 2023 to USD 5.11 Billion by 2033, at a Compound Annual Growth Rate...
Warning: September Asthma Spike Ahead
August 22, 2024 07:00 ET
|
Asthma and Allergy Foundation of America
Washington, DC, Aug. 22, 2024 (GLOBE NEWSWIRE) -- The Asthma and Allergy Foundation of America (AAFA) today warned about a combination of factors coming together to make September the worst month of...
EXTR SHAREHOLDER ALERT: Contact BFA Law by October 15 about the Securities Fraud Class Action Lawsuit if You Lost Money on Your Extreme Networks, Inc. Investment (NASDAQ:EXTR)
August 22, 2024 06:17 ET
|
Bleichmar Fonti & Auld
Extreme Networks, Inc. investors that lost money on their investment are encouraged to contact BFA Law before October 15, 2024 legal deadline.